-
Roche, Canadian Not-for-Profit to Partner on New Drugs
The Centre for Drug Research and Development (CDRD) in Vancouver, Canada and Swiss pharmaceutical maker F. Hoffmann-La Roche Ltd. have agreed to collaborate on development and commercialization of new drug therapies. The exact therapies are yet to be defined, according to the announcement, but will be “for the treatment of diseases with high unmet medical…
-
NSF Grant to Fund Research on Power Distribution
A team of engineers and computer scientists at Kansas State University in Manhattan have received a $1.1 grant to research better ways of distributing solar power to homes and businesses. The grant, funded by National Science Foundation’s Cyber-Physical Systems program, aims to give utilities generating solar energy better tools for managing and distributing this power.…
-
Clemson University Creates Sustainable Vehicle Center
Clemson University in Greenville, South Carolina has received a $1 million grant from the U.S. Department of Energy for a research and education program in sustainable vehicle systems. The program will be part of Clemson’s International Center for Automotive Research. The new program at Clemson aims to overcome barriers in the design and development of…
-
Gold Nanowires Add Conductivity to Heart Tissue Patches
Researchers at Children’s Hospital Boston and the Massachusetts Institute of Technology have found a way to improve the performance of engineered heart tissue patches with gold nanowires. The findings from the team of physicians, engineers, and materials scientists appear online in the journal Nature Nanotechnology (paid subscription required). Patches of engineered heart tissue, made with…
-
Kauffman Global Scholars Program Applications Now Open
The Global Scholars Program, a six-month training program on entrepreneurship offered by the Ewing Marion Kauffman Foundation in Kansas City, Missouri is now accepting applications for 2012. The foundation encourages recent (since 2009) undergraduate or graduate degree recipients with ideas for new businesses in the natural or physical sciences, technology, and engineering fields. Applicants need…
-
NYU to Study Response of Rice to Environmental Change
The National Science Foundation’s Plant Genome Research Program has awarded a $3.6 million grant to New York University to study the response of rice to environmental change. NYU’s Michael Purugganan and Richard Bonneau, who are part of the university’s Center for Genomics and Systems Biology, will head the study, and collaborate with Endang Septiningsih of…
-
Likely Cause of Vertigo from MRI Identified
Researchers at Johns Hopkins University in Baltimore have found what they believe is a likely cause of the dizzy feeling patients experience when subjected to magnetic resonance imaging (MRI) scans. The findings from the team led by systems engineer Dale Roberts appear online in the journal Current Biology. Many patients undergoing MRI scans complain of…
-
Mapping Project to Find Innovation, Entrepreneurial Networks
The University of Maryland in College Park will develop analytical mapping tools that identify innovation and entrepreneurial networks, and help spot opportunities for new business collaborations. The project, funded by part of a $500,000 grant from U.S. Department of Commerce, is based on research conducted by a Maryland doctoral candidate in urban and regional planning.…
-
Technology Developed for Aerial Vegetation Measurements
A scientist with the U.S. Department of Agriculture and a technical consultant from industry have developed and patented a technology that converts digital cameras to color infrared cameras for aerial photography. Raymond Hunt, with USDA’s Agricultural Research Service in Beltsville, Maryland and David Linden, chief scientist at Science Applications International Corporation (SAIC) in McLean, Virginia…
-
U.S. Biotech Gets Approval for Stem Cell Trial in Europe
Advanced Cell Technology Inc. in Marlborough, Massachusetts has received clearance from authorities in the U.K. to begin treating patients with compounds derived from human embryonic stem cells (hESCs) as part of a clinical trial. The approval from the U.K. Medicines and Healthcare Products Regulatory Agency involves a test of retinal pigment epithelium (RPE) from hESCs…